Skip to main content

Table 1 Demographic, clinical, and therapeutic features of childhood Takayasu’s arteritis (c-TA)

From: Clinical course and prognostic factors of childhood Takayasu’s arteritis: over 15-year comprehensive analysis of 101 patients

  Median/n IQR/%
Demographic features
 Age at Takayasu’s arteritis onset, years 14 12–16
 Delay to diagnosis/admission, years 0.6 0.2–2.1
 BMI (kg/m2) 19.7 17.6–21.4
 Sex (female) 77 76.2
Clinical presentations
 Hypertension 71 70.3
 Blood pressure discrepancy 56 55.4
 Bruits 52 51.5
 Pulse deficits 38 37.6
 Dyspnea 30 29.7
 Dizziness 27 26.7
 Heart failure 25 24.8
 Claudication 23 22.8
 Fever 13 12.9
 Syncope 10 9.9
 Stroke 6 5.9
 Carotidynia 4 4
 Myocardial infarction/ischemia 3 3
Retinopathy 38 37.6
 Direct inflammation involvement 20 19.8
 Secondary to hypertension 17 16.8
Angiographic classification
 Type I 12 11.9
 Type IIa 0 0
 Type IIb 10 9.9
 Type III 9 8.9
 Type IV 38 37.6
 Type V 32 31.6
Laboratory results
 Elevated ESR 33 32.7
 Elevated CRP 35 34.7
Medications
 Glucocorticoids 79 78.2
 Immunosuppressant 11 10.9
 Antiplatelet drugs 73 72.3
 Antihypertensive drugs 73 72.3
Revascularization 58 57.4
 Balloon angioplasty 41 40.6
 Stenting 22 21.8
 Surgery 8 7.9
  1. BMI body mass index, CRP C-reactive protein, ESR erythrocyte sedimentation rate, IQR interquartile range